Successful treatment of chronic urticaria with a Japanese herbal medicine, yokukansan

Journal of Dermatology

Volumn 37, Issue 12, 2010, Pages 1066-1067

  Kato, Shiori ^a   Kato, Takahiro A ^a   Nishie, Haruko ^a   Nishima, Sankei ^a   Iwanaga, Tomoaki ^a   Monji, Akira ^a   Nakano, Misa ^b   Takeshita, Hiromichi ^a   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b STEEL MEMORIAL YAWATA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZELASTINE; BETOTASTINE; CETIRIZINE; CYPROHEPTADINE; DEXAMETHASONE; DEXCHLORPHENIRAMINE MALEATE; EBASTINE; EMBONIC ACID; EPINASTINE; FEXOFENADINE; HERBACEOUS AGENT; HYDROXYZINE; LORATADINE; MEQUITAZINE; MONTELUKAST; OLOPATADINE; PRANLUKAST; PREDNISOLONE; TRANEXAMIC ACID; UNCLASSIFIED DRUG; YOKUKANSAN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; CHRONIC URTICARIA; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG EFFICACY; FEMALE; HERBAL MEDICINE; HUMAN; JAPANESE; LETTER; SCORING SYSTEM; TREATMENT RESPONSE;

ADULT; AGED; CHRONIC DISEASE; DERMATOLOGIC AGENTS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MIDDLE AGED; PHYTOTHERAPY; TREATMENT OUTCOME; URTICARIA; YOUNG ADULT;

EID: 78649637980     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00937.x     Document Type: Letter

References (9)

1. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-1426.
2. Gupta MA, Gupta AK,. Antidepressant drugs in dermatology. Skin Therapy Lett 2001; 6: 3-5.
3. Thormann H, Bindslev-Jensen C,. Mirtazapine for chronic urticaria. Acta Derm Venereol 2004; 84: 482-483.
4. Staubach P, Eckhardt-Henn A, Dechene M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006; 154: 294-298.
5. Bigata X, Sais G, Soler F,. Severe chronic urticaria: response to mirtazapine. J Am Acad Dermatol 2005; 53: 916-917.
6. Monji A, Takita M, Samejima T, et al. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 308-311.
7. Miyaoka T, Furuya M, Yasuda H, et al. Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study. Clin Neuropharmacol 2009; 32: 6-9.
8. Mizoguchi K, Tanaka Y, Tabira T,. Anxiolytic effect of a herbal medicine, yokukansan, in aged rats: Involvement of serotonergic and dopaminergic transmissions in the prefrontal cortex. J Ethnopharmacol 2010; 127: 70-6.
9. Jiang J, Yamaguchi T, Funakushi N, et al. Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice. J Dermatol Sci 2009; 56: 37-42.